Demand to Short Japan s Aozora Rises Even After 34% Stock Plunge bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionIndia-Canada Clash Should Be a Wakeup CallWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundIndians Have Five Days to Deposit $3 Billion in Soon-to-Be-Withdrawn BanknotesCorzine Plans to Shut Hedge Fund and Return Cap
Japan s Nikkei share average
gave up small gains to trade lower on Wednesday ahead of U.S.
inflation, but the losses were limited as investors bought value
shares that withstand higher rates. .
Chinese chat pages have been flooded with posts about boycotting Japanese products, including on Weibo, one of the country’s largest social media platforms.